No HLA-A gene detectable on one of the haplotypes in a caucasian family

Human Immunology

Volumn 66, Issue 2, 2005, Pages 155-163

  Swelsen, Wendy T N ^a   Voorter, Christina E M ^a   Tilanus, Marcel G J ^c   Kamps, Miriam A F ^b   Van Den Berg Loonen, Ella M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Deletion; FISH; HLA A; Microsatellite markers; Null allele

Indexed keywords

HLA A ANTIGEN;

ARTICLE; CAUCASIAN; CONTROLLED STUDY; COSMID; FAMILY STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE IDENTIFICATION; GENETIC ANALYSIS; HAPLOTYPE; HETEROZYGOSITY; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOGENETICS; MICROSATELLITE MARKER; MOLECULAR GENETICS; MOLECULAR PROBE; NULL ALLELE; PRIORITY JOURNAL; SEROLOGY;

EID: 13444266204     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2004.10.009     Document Type: Article

References (51)

1. Robinson J, Waller MJ, Parham P, Groot de N, Bontrop R, Kennedy LJ, Stoehr P, Marsh SGE: IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res 31: 311, 2003.
2. Lardy NM, Otting N, Horst van der AR, Bontrop RE, Waal de LP: 5′ Regulatory nucleotide sequence of an HLA-A*0101null allele. Immunogenetics 46:152, 1997.
3. Lee KW, Shin J-Y, Lee J-Y: Expression defect of an HLA-A*24 allele associated with DNA methylation in a normal individual. Tissue Antigens 61:325, 2003.
4. Magor KE, Taylor EJ, Shen SY, Martinez-Naves E, Valiante NM,Wells RS, Gumperz JE, Adams EJ, Little A-M, Williams F, Middleton D, Gao X, McCluskey J, Parham P, Lienert-Weidenbach K: Natural inactivation of a common HLA allele (A*2402) has occurred on at least three separate occasions. J Immunol 158:5242, 1997.
5. Zanone-Ramseier R, Gratwohl A, Gmür J, Roosnek E, Tiercy JM: Sequencing of two HLA-A blank alleles: implications in unrelated bone marrow donor matching. Transplantation 67:1336, 1999.
6. Laforet M, Froelich N, Parissiadis A, Bausinger H, Pfeiffer B, Tongio MM: An intronic mutation responsible for a low level of expression of an HLA-A*24 allele. Tissue Antigens 50:340, 1997.
7. Balas A, García-Sánchez F, Gómez-Reino F, Vicario JL: HLA class I allele (HLA-A2) expression defect associated with a mutation in its enhancer B inverted cat box in two families. Hum Immunol 41:69, 1994.
8. Bunce M, Procter J, Dunn PPJ, Day S, Ross J, Welsh KI: Identification of the null HLA-A2 allele, A*0232N. Tissue Antigens 55:31, 2000.
9. Wu G-G, Cheng L-H, Deng Z-H, Wang L-X, Wei T-L, Yang C-S, Zhao T-M: Cloning and complete sequence of a novel HLA-A null allele, A*0253N, with a termination codon generated by a C to G mutation in exon 2. Tissue Antigens 59:328, 2002.
10. Ishikawa Y, Tokunaga K, Tanaka H, Nishimura M, Muraoka M, Fujii Y, Akaza T, Tadokoro K, Juiji T: HLA-A null allele with a stop codon, HLA-A*0215N, identified in a homozygous state in a healthy adult. Immunogenetics 43:1, 1995.
11. Li J, Hollander den N, Oosterwijk van A, Ng C-M, Singai DP: Identification of a new HLA-A null allele, A*2436N. Tissue Antigens 60:184, 2002.
12. Laforet M, Froelich N, Parissiadis A, Schell A, Pfeiffer B, Cazenave JP, Tongio MM: A null HLA-A*68 allele in a bone marrow donor. Tissue Antigens 53:573, 1999.
13. Laforet M, Froelich N, Parissiadis A, Pfeiffer B, Schell A, Faller B, Woehl-Jaegle M-L, Cazenave J-P, Tongio MM: A nucleotide insertion in exon 4 is responsible for the absence of expression of an HLA-A*01 allele. Tissue Antigens 50:347, 1997.
14. Dormoy A, Froelich N, Parissiadis A, Cazenave J-P, Tongio MM: Second HLA-A*68 null allele, A*6818N, identified. Tissue Antigens 60:88, 2002.
15. Lienert K, Russ G, Lester S, Bennett G, Gao X, McCluskey J: Stable inheritance of an HLA-"blank" phenotype associated with a structural mutation in the HLA-A*0301 gene. Tissue Antigens 48:187, 1996.
16. Elsner H-A, Bernard G, Eiz-Vesper B, Matteis de M, Bernard A, Blasczyk R: Non-expression of HLA-A*2901102N is caused by a nucleotide exchange in the mRNA splicing site at the beginning of intron 4. Tissue Antigens 59:139, 2002.
17. van den Berg-Loonen PM, Savelkoul P, van Hooff H, van Eede P, Riesewijk A, Geraedts J: Uniparental maternal disomy 6 in a renal transplant patient. Hum Immunol 45:46, 1996.
18. Eggermann T, Marg W, Mergenthaler S, Eggerman K, Schemmel V, Stoffers U, Zerres K, Spranger S: Origin of uniparental disomy 6: presentation of a new case and review on the literature. Ann Genet 44:41, 2001.
19. Crowley J, Hagan R, Clancy D, Rooney G, Dunne C, Lawlor E, Hayden P, Little AM, Soteriou B, Marsh SGE, Madrigal JA: Two sets of HLA class II DRB and DQB1 alleles co-segregate among family members in a single maternal haplotype. Tissue Antigens 61:487, 2003.
20. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215, 1988.
21. Voorter CEM, van der Vlies SA, van den Berg-Loonen EM: Sequence-based typing of HLA-B: the B7 cross-reacting group. Tissue Antigens 56:356, 2000.
22. Bunce M, Barnardo MCNM, Welsh KI: Improvements in HLA-C typing using sequence-specific primers (PCR-SSP) including definition of HLA-Cw9 and Cw10 and a new allele HLA"Cw7/8v."Tissue Antigens 44:200, 1994.
23. van der Vlies SA, Voorter CEM, van den Berg-Loonen EM: A reliable and efficient high resolution typing method for HLA-C using sequence-based typing. Tissue Antigens 52:558, 1998.
24. Voorter CEM, Rozemuller EH, de Bruyn-Geraets D, van der Zwan AW, Tilanus MGJ, van den Berg-Loonen EM: Comparison of DRB sequence-based typing using different strategies. Tissue Antigens 49:471, 1997.
25. Voorter CEM, de Bruyn-Geraets D, van den Berg-Loonen EM: High-resolution HLA typing for the DRB3/4/5 genes by sequence-based typing. Tissue Antigens 50:283, 1997.
26. Voorter CEM, Kik MC, van den Berg-Loonen EM: High-resolution HLA typing for the DQB1 gene by sequence-based typing. Tissue Antigens 51:80, 1998.
27. Wu G-G, Cheng L-H, Li Z, Deng Z-H, Zou H-Y, Wei T-L, Zhou D, Li D-C, Gao S-Q, Zhao TM: Identification of a new HLA allele, A*1114, in a Chinese family. Tissue Antigens 61:253, 2003.
28. Foissac A, Salhi M, Cambon-Thomsen A: Microsatellites in the HLA region: 1999 update. Tissue Antigens 55:477, 2000.
29. Lie BA, Todd JA, Pociot F, Nerup J, Akelsen HE, Joner G, Rønningen Dahl-Jørgensen, KS, Thorsby E, Undlien DE: The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am J Hum Genet 64:793, 1999.
30. th International Histocompatibility Working Group. Eds: Tilanus MGJ, Hansen JH, Hurley CK. Publisher: Fred Hutchinson Cancer Research Center, Seattle, WA USA.
31. Riemersma SA, Jordanova ES, Schop RFJ, Phillippo K, Looijenga LHJ, Schuuring E, Kluin PM: Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites. Blood 96:3569, 2000.
32. Shiina T, Tamiya G, Oka A, Takishima N, Inoko H: Genome sequencing analysis of the 1.8 Mb entire human MHC class I region. Immunol Rev 167:193, 1999.
33. Pichon L, Carn G, Bouric P, Giffon T, Chauvel B, Lepourcelet M, Mosser J, Legall J-Y, David V: Structural analysis of the HLA-A/HLA-F subregion: precise localization of two new multigene families closely associated with the HLA class I sequences. Genomics 32:236, 1996.
34. Voorter CEM, Ummelen MIJ, Ramaekers FSC, Hopman AHN: Loss of chromosome 11 and 11 p/q imbalances in bladder cancer detected by fluorescence in situ hybridization. Int J Cancer 65:301, 1996.
35. Hopman AHN, Voorter CEM, Speel EJM, Ramaekers FCS, Vooijs PG: Detection of genetic changes in cancer by interphase cytogenetics and comparative genomic hybridization. In Polak JM, McGee JOD (eds): In Situ Hybridization. 2nd edition. London: Oxford University Press, 1998.
36. Young NT, Darke C: Molecular characterization of the HLA-DR2LUM haplotype. Tissue Antigens 43:28, 1994.
37. Corell A, Varela P, Morales P, Paz-Artal E, Martínez-Laso J, Martín-Villa JM, Toit du E, Arnaiz-Villena A: A study of DR2-LUM haplotype generation and the DRB6*0202 linkage to DRB1*1601. Immunogenetics 38:460, 1993.
38. Wade JA, Hurley CK, Hastings A, Ehrenberg P, Johnson AH, Martell RW, Toit du ED: Combinatorial diversity in DR2 haplotypes. Tissue Antigens 41:113, 1993.
39. Tautz C, Marsh DG, Baur X: A novel HLA-haplotype containing a DRB5 gene not associated with DRB1*15 or DRB1*16 alleles. Tissue Antigens 39:91, 1992.
40. Perrier P, Leotard B, Henry MA: A novel HLA haplotype containing a DRB5 gene associated with the DRB1*0103 allele. Tissue Antigens 42:518, 1993.
41. van den Berg-Loonen EM, Bignon JD, du Toit E, Pitchappan RM, Loon J, Singal DP, Olerup O, Perrier P, Constantinidou N, Papasteriades C, Schreuder G, Arnaiz-Villena A, Breda-Coimbra H, Poli F, Hashemi S, le Petit JC, Scorza R, Palma Carlos A, Bartova A, Moraes JR, Tilanus M, Rani R, Manzo C, Kamoun M, Cheung KWK, Nose Y, Lenhard V, Gandini E, Tongio MM, Sachs J, Hansen JA, Emonds MP, Stewart D: AHS#11: HLA-DR2 (DR15, DR16), DR51. In Charron D (ed): Twelfth International Histocompatibility Workshop and Conference. Volume 1. Saint Malo: EDK, 1997.
42. Das S, Lese CM, Song M, Jensen JL, Wells LA, Barnoski BL, Roseberry JA, Camacho JM, Ledbetter DH, Schnur RE: Partial paternal uniparental disomy of chromosome 6 in an infant with neonatal diabetes, macroglossia, and craniofacial abnormalities. Am J Hum Genet 67:1586, 2000.
43. López-Gutiérrez AU, Riba L, Ordoñez-Sánchez ML, Ramírez-Jiménez S, Cerillo-Hinojosa M, Tusié-Luna MT: Uniparental disomy for chromosome 6 results in steroid 21-hydroxylase deficiency: evidence of different genetic mechanisms involved in the production of the disease. J Med Genet 35:1014, 1998.
44. Carter V, Dunn PPJ, Cavanagh G, Day S, Ross J, Chapman C: An HLA-B null allele (B*0808N) caused by a nucleotide deletion in exon 3, found in the family of a bone marrow transplant recipient. Tissue Antigens 55:61, 2000.
45. Dunne C, Little AM, Cox ST, Masson D, Crowley J, Barnes T, Marsh SGE, Rooney G, Hagan R, Lawlor E, Madrigal JA: Identification and nucleotide sequence of a new null allele, HLA B*3540N. Tissue Antigens 59:522, 2002.
46. Bettens F, Tiercy JM: Sequence of a new class I null allele within the HLA-B44-specificity. Tissue Antigens 56:441, 2000.
47. Balas A, Santos S, Aviles MJ, García-Sánchez F, Lillo R, Alvarez A, Villar-Guimerans LM, Vicario JL: Elongation of the cytoplasmic domain, due to a point deletion at exon 7, results in an HLA-C null allele, Cw*0409N. Tissue Antigens 59:95, 2002.
48. Balas A, Ocon P, Vicario JL, Alonso A: HLA-DR51 expression failure caused by a two-base deletion at exon 2 of a DRB5 null allele (DRB5*0110N) in a Spanish gypsy family. Tissue Antigens 55:467, 2000.
49. Curran MD, Williams F, Little AM, Rima BK, Madrigal JA, Middleton D: Aberrant splicing of intron 1 creates a novel null HLA-B*1501 allele. Tissue Antigens 53:244, 1999.
50. Robbins F, Hurley CK, Tang T, Yao H, Lin Y, Wade J, Goeken N, Hartzman RJ: Diversity associated with the second expressed HLA-DRB locus in the human population. Immunogenetics 46:104, 1997.
51. Voorter CEM, Roeffaers HET, du Toit ED, van den Berg-Loonen EM: The absence of DR51 in a DRB5-positive individual DR2ES is caused by a null allele (DRB5*0108N). Tissue Antigens 50:326, 1997.